Teladoc Health Inc (TDOC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -63,837 | -200,322 | -175,179 | -125,672 | -93,012 |
| Depreciation Amortization | 94,185 | 448,197 | 348,975 | 244,198 | 149,311 |
| Income taxes - deferred | -1,060 | -41,407 | -31,449 | -34,072 | -26,865 |
| Accounts receivable | -20,996 | 25,126 | 7,664 | -8,497 | -15,270 |
| Accounts payable and accrued liabilities | -2,108 | 11,454 | 16,256 | 19,278 | 17,356 |
| Other Working Capital | -35,633 | 1,075 | -3,026 | -27,036 | -40,490 |
| Other Operating Activity | 38,965 | 50,234 | 43,374 | 39,152 | 24,889 |
| Operating Cash Flow | $9,516 | $294,357 | $206,615 | $107,351 | $15,919 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -700 | 740 | 740 | -26,335 | -27,075 |
| PPE Investments | -35,822 | -127,455 | -93,136 | -61,818 | -31,585 |
| Net Acquisitions | N/A | -81,904 | -81,904 | -65,302 | -64,608 |
| Purchase Of Investment | N/A | -27,875 | -27,875 | N/A | N/A |
| Purchase Sale Intangibles | N/A | -29,569 | -29,569 | -29,569 | N/A |
| Other Investing Activity | 0 | -29,509 | -29,509 | -29,509 | 0 |
| Investing Cash Flow | $-36,522 | $-266,003 | $-231,684 | $-182,964 | $-123,268 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | N/A | -550,629 | -550,629 | -550,629 | N/A |
| Common Stock Issued | 399 | 3,085 | 1,982 | 1,465 | 769 |
| Other Financing Activity | -2,848 | -4,108 | -4,109 | 0 | 0 |
| Financing Cash Flow | $-2,449 | $-551,652 | $-552,756 | $-549,164 | $769 |
| Exchange Rate Effect | -891 | 6,055 | 5,747 | 6,071 | 1,585 |
| Beginning Cash Position | 781,084 | 1,298,327 | 1,298,327 | 1,298,327 | 1,298,327 |
| End Cash Position | 750,738 | 781,084 | 726,249 | 679,621 | 1,193,332 |
| Net Cash Flow | $-30,346 | $-517,243 | $-572,078 | $-618,706 | $-104,995 |
| Free Cash Flow | |||||
| Operating Cash Flow | 9,516 | 294,357 | 206,615 | 107,351 | 15,919 |
| Capital Expenditure | -35,822 | -127,455 | -93,136 | -61,818 | -31,585 |
| Free Cash Flow | -26,306 | 166,902 | 113,479 | 45,533 | -15,666 |